Source (realclearpolitics)
READ MORE: https://www.justice.gov/opa/pr/novo-nordisk-agrees-pay-58-million-failure-comply-fda-mandated-risk-program
http://www.business.dk/medico/novo-nordisk-indgaar-forlig-paa-366-millioner-kroner
https://www.novonordisk.com/bin/getPDF.2126247.pdf
https://www.novonordisk.com/bin/getPDF.2165236.pdf
https://www.reuters.com/article/us-novo-nordisk-usa/novo-nordisk-gets-nod-from-u-s-drug-purchaser-for-new-diabetes-hope-idUSKCN1G527C
http://nyheder.tv2.dk/erhverv/2016-11-02-feel-the-bern-sanders-gar-i-flaesket-pa-novo-nordisk
https://www.rt.com/usa/365026-bernie-sanders-insulin-prices/
Victoza
Victoza is Novo Nordisk’s blockbuster, once-daily injectable Type 2 diabetes drug that stimulates insulin production in the body. In addition to decreasing blood sugar, studies have shown that Victoza can increase weight loss and decrease risk of cardiovascular events, such as heart attack, stroke, and related death. However, studies have linked Victoza to serious side effects, including thyroid cancer and pancreatitis.
No comments:
Post a Comment